康宁杰瑞制药-B:于2025年AACR年会呈列的JSKN021及JSKN022的最新研究成果

格隆汇
30 Apr

格隆汇4月30日丨康宁杰瑞制药-B(09966.HK)发布公告,JSKN021及JSKN022临床前研究的最新成果已于2025年4月25日至4月30日举行的2025年AACR年会(2025年美国癌症研究协会年会,美国癌症研究协会为致力于攻克癌症的成立最早、规模最大的癌症研究组织之一)的壁报展示期间(摘要展示编号:5450及5451)公布。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10